Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients.

Ballani P, Tran MT, Navar MD, Davidson MB. Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients. Diabetes Care. 2006 Nov; 29(11):2504-5.

View in: PubMed

subject areas

Adult
Algorithms
Diabetes Mellitus, Type 2
Female
Humans
Hypoglycemic Agents
Insulin
Insulin Resistance
Male
Middle Aged
Obesity
Treatment Outcome
Weight Gain

authors with profiles

Mayer B. Davidson, MD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support